Literature DB >> 20633538

RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts.

Parul Sharma1, Somying Patntirapong, Steven Hann, Peter V Hauschka.   

Abstract

Formation of multinucleated bone-resorbing osteoclasts results from activation of the receptor activated NF-kappaB ligand (RANKL)-receptor activated NF-kappaB (RANK) signaling pathway in primary bone marrow macrophages and a macrophage cell line (RAW 264.7). Osteoclasts, through bone remodeling, are key participants in the homeostatic regulation of calcium and phosphate levels within the body. Microarray analysis using Gene Expression Dynamic Inspector (GEDI) clustering software indicated that osteoclast differentiation is correlated with an increase in xenotropic and polytropic virus receptor 1 (XPR1) mRNA transcripts. XPR1 is a receptor of the xenotropic and polytropic murine leukemia virus and homolog of yeast Syg1 and plant Pi transporter PHO1. Quantitative PCR was used to validate the up-regulation of XPR1 message following RANKL stimulation in both primary bone marrow cells and a macrophage cell line. Immunostaining for the XPR1 protein showed that there is translocation of XPR1 to the membranes of the sealing zone in mature osteoclasts. This study is the first to demonstrate that the expression of retro-viral receptor, XPR1, is regulated by RANKL-RANK signaling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633538      PMCID: PMC4667747          DOI: 10.1016/j.bbrc.2010.07.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  A band of F-actin containing podosomes is involved in bone resorption by osteoclasts.

Authors:  J Kanehisa; T Yamanaka; S Doi; K Turksen; J N Heersche; J E Aubin; H Takeuchi
Journal:  Bone       Date:  1990       Impact factor: 4.398

2.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

3.  Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis.

Authors:  J Schmidt; K Lumniczky; B D Tzschaschel; H L Guenther; A Luz; S Riemann; W Gimbel; V Erfle; R G Erben
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

4.  A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients.

Authors:  M H Helfrich; R P Hobson; P S Grabowski; A Zurbriggen; S L Cosby; G R Dickson; W D Fraser; C G Ooi; P L Selby; A J Crisp; R G Wallace; S Kahn; S H Ralston
Journal:  J Bone Miner Res       Date:  2000-12       Impact factor: 6.741

5.  Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors.

Authors:  J Faust; D L Lacey; P Hunt; T L Burgess; S Scully; G Van; A Eli; Y Qian; V Shalhoub
Journal:  J Cell Biochem       Date:  1999-01-01       Impact factor: 4.429

6.  Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses.

Authors:  M Marin; C S Tailor; A Nouri; S L Kozak; D Kabat
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction.

Authors:  J L Battini; J E Rasko; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.

Authors:  Anaïs Mozar; Nathalie Haren; Maud Chasseraud; Loïc Louvet; Cécile Mazière; Alice Wattel; Romuald Mentaverri; Patrice Morlière; Saïd Kamel; Michel Brazier; Jean C Mazière; Ziad A Massy
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

9.  Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses.

Authors:  C S Tailor; A Nouri; C G Lee; C Kozak; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

Review 10.  Interactions between vacuolar H+-ATPases and microfilaments in osteoclasts.

Authors:  L Shannon Holliday; Michael R Bubb; Jin Jiang; I Rita Hurst; Jian Zuo
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

View more
  8 in total

Review 1.  Regulation of renal phosphate handling: inter-organ communication in health and disease.

Authors:  Sawako Tatsumi; Atsumi Miyagawa; Ichiro Kaneko; Yuji Shiozaki; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2015-08-22       Impact factor: 2.626

Review 2.  The mouse "xenotropic" gammaretroviruses and their XPR1 receptor.

Authors:  Christine A Kozak
Journal:  Retrovirology       Date:  2010-11-30       Impact factor: 4.602

3.  Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity.

Authors:  Christine A Kozak
Journal:  Adv Virol       Date:  2011-10-23

4.  Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate.

Authors:  P Edward Purdue; Tania N Crotti; Zhenxin Shen; Jennifer Swantek; Jun Li; Jonathan Hill; Adedayo Hanidu; Janice Dimock; Gerald Nabozny; Steven R Goldring; Kevin P McHugh
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

5.  Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling.

Authors:  Eunkyung An; Manikandan Narayanan; Nathan P Manes; Aleksandra Nita-Lazar
Journal:  Mol Cell Proteomics       Date:  2014-07-20       Impact factor: 5.911

6.  The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: evidence from network pharmacology, molecular docking and experimental validation.

Authors:  Xiaojun Chen; Jiangyan Wang; Lin Tang; Qiuying Ye; Qunwei Dong; Zhangwei Li; Li Hu; Chenghong Ma; Jiake Xu; Ping Sun
Journal:  Aging (Albany NY)       Date:  2022-07-12       Impact factor: 5.955

7.  Sodium-dependent phosphate transporters in osteoclast differentiation and function.

Authors:  Giuseppe Albano; Matthias Moor; Silvia Dolder; Mark Siegrist; Carsten A Wagner; Jürg Biber; Nati Hernando; Willy Hofstetter; Olivier Bonny; Daniel G Fuster
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis.

Authors:  Kyunghwan Kim; Vasu Punj; Jin-Man Kim; Sunyoung Lee; Tobias S Ulmer; Wange Lu; Judd C Rice; Woojin An
Journal:  Genes Dev       Date:  2016-01-07       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.